Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PROGENICS PHARMACEUTICALS IN Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 119.31 M 130.42 M 125.79 M 166.06 M 30.22 M
    Net Receivables 1.34 M 2.00 M 1.70 M 3.29 M 1.30 M
    Total Inventories 0.00 0.00 0.00 0.00 0.00
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses
    Other Current Assets 3.53 M 3.11 M 3.18 M 2.56 M 1.81 M
    Current Assets Total 124.18 M 135.53 M 130.67 M 171.90 M 33.33 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 371,000.00 0.00
    Other Investments 22.58 M 40.50 M 23.86 M 7.04 M 1.52 M
    Property, Plant & Equipment Net 11.07 M 13.51 M 11.39 M 4.16 M 4.69 M
    Property, Plant & Equipment Gross 27.70 M 25.68 M 20.62 M 11.96 M 11.03 M
    Accumulated Depreciation 16.63 M 12.17 M 9.23 M 7.81 M 6.34 M
    Other Assets 0.00 0.00 0.00 538,000.00 0.00
    Deferred Charges 0.00 0.00 0.00 0.00 0.00
    Tangible Other Assets 538,000.00 532,000.00
    Intangible Other Assets 0.00 0.00 0.00 0.00 0.00
    Total Assets 157.83 M 189.54 M 165.91 M 184.00 M 39.54 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 0.00 0.00 0.00 0.00
    Accrued Payroll 1.09 M 1.49 M 990,000.00 1.14 M 734,000.00
    Income Taxes Payable 0.00 0.00 0.00 201,000.00 0.00
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 36.21 M 29.90 M 36.29 M 32.58 M 5.49 M
    Current Liabilities Total 38.20 M 32.55 M 38.84 M 34.80 M 7.66 M
    Long Term Debt 0.00 0.00 0.00 0.00 0.00
    Provision for Risks & Charges
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 9.13 M 16.10 M 36.42 M
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 266,000.00 359,000.00 123,000.00 49,000.00 42,000.00
    Total Liabilities 38.46 M 42.04 M 55.06 M 71.27 M 7.71 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 119.37 M 147.50 M 110.85 M 112.73 M 31.84 M
    Common Stock 40,000.00 39,000.00 34,000.00 33,000.00 22,000.00
    Capital Surplus 422.08 M 401.50 M 321.32 M 306.08 M 153.47 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves -1.30 M 6,000.00 -145,000.00 -4.50 M -2.25 M
    Unappropriated (Free) Reserves 0.00 0.00 0.00 0.00 0.00
    Retained Earnings -298.72 M -254.05 M -210.36 M -188.74 M -119.31 M
    Equity in Untaxed Reserves
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities -148,000.00 -91,000.00 14,000.00
    Treasury Stock 2.74 M 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 157.83 M 189.54 M 165.91 M 184.00 M 39.54 M
    Common Shares Outstanding 28.07 M 29.75 M 26.20 M 25.23 M 17.28 M